Related Experiment Video
Updated: May 7, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Reversible white matter lesions during ketogenic diet therapy in glucose transporter 1 deficiency syndrome
Tadashi Shiohama1, Katsunori Fujii, Satoru Takahashi
1Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan.
Background:
Glucose transporter type 1 deficiency syndrome is caused by brain energy failure resulting from a disturbance in glucose transport.
Patients:
We describe a 4-year-old boy with classical type glucose transporter type 1 deficiency syndrome with a heterozygous splice acceptor site mutation (c.517-2A>G) in the SLCA2A1 gene.
Results:
We initiated a ketogenic diet at 4 months of age. However, even though his condition was good during ketogenic diet therapy, multiple cerebral white matter and right cerebellum lesions appeared at 9 months of age. The lesions in the cerebral white matter subsequently disappeared, indicating that white matter lesions during diet therapy may be reversible and independent of the ketogenic diet.
Conclusions:
This is the first report of reversible white matter lesions during ketogenic diet therapy in glucose transporter type 1 deficiency syndrome.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic Ketoacidosis l: Introduction
Inborn Errors of Metabolism
Glucose Absorption Into the Small Intestine
Ischemic Stroke ll: Pathophysiology

